| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 14, 2024 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Save time and jump to the most important pieces.
10-K/A - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
8-K - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
10-K - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies specialist with experience in early-stage commercialization of minimally invasive surgical products and procedures. Most recently, he served as VP Business Development, Commercial Strategy, CRO, an
GARDNER, Mass, June 12, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Wayne Coll as Chief Financial Officer (CFO), effective June 12, 2023. With a career spanning more than 30 years, Coll is an experienced public company CFO, including experience at publicly-held National Dentex Corporation and Micron Solutions, and privately-held Flowonix Medical Incorporated, Keystone Dental, Modern Dental Laboratory USA and Pluromed. Coll replaces Interim CFO Kevin Dahill.
GARDNER, Mass., April 17, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of medical device and aerospace/defense industry manufacturing veteran, Mahesh Lawande, as the Company's Chief Operating Officer effective April 24, 2023. In the newly created role, Lawande will lead Precision Optics operations team, including its sales & marketing, production and engineering activities at its facilities in Massachusetts, Maine and Texas.
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
– SEC Filing
Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system. The assembly draws on POC's unique micro-optics and digital imaging technologies. This is the largest order POC has ever received and illustrates the opportunities that single-use applications provide to the Company. Production deliveries are scheduled to begin July 2024 and proceed over several quarters. The Company presently estimates approximately $2.2 million in deliveries d
SC 13G - PRECISION OPTICS CORPORATION, INC. (0000867840) (Subject)
GARDNER, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) ("POC"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that its customer, a surgical robotics company focused on transformative solutions in urology, recently announced FDA 510(k) clearance of its next-generation AI-powered platform for treatment of Benign Prostate Hyperplasia. Precision Optics designed and currently manufactures the single-use endoscope imaging assembly used within the new system. "We are excited by the news and congratulate our customer's entire team on receiving FDA 510(k) clearance for their re
GARDNER, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced today it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually today, Tuesday, October 1, 2024. Company Webcast Precision Optics' webcast presentation will begin at 1:15 pm ET on Tuesday, October 1. Access will be available via the conference home page at https://lythampartners.com/fall2024/ or directly at https://app.webinar.net/qvBOJq
GARDNER, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2024. FY 2024 Financial Highlights (Year Ended June 30, 2024): Revenue was $19.1 million compared to $21.0 million in the previous fiscal year. Revenue of $19.1 million, exceeded the high end of the expected range announced on August 14, 2024 of $18.9 million.Production revenue was $10.8 million, a decrease of 25% compared to the previous fiscal year.Engineering revenue
GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's fourth quarter and fiscal year 2024 financial results on Monday, September 30, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 30, 2024, followed by the conference call. Conference Call Details Date and Time: Monday, September 30, 2024, at 5:00pm ET Call-in Informa
GARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024. Q3 2024 Financial Highlights (3 Months Ended March 31, 2024): Revenue increased 4% to $5.2 million, compared to $5.0 million in the same quarter of the previous fiscal year, and up 9% compared to the most recent sequential quarter.Engineering revenue increased 62% to $2.3 million compared to $1.4 million in the same quarter of the previous fiscal year, represen
GARDNER, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss third quarter of fiscal year 2024 financial results on Wednesday, May 15, 2024, at 5:00pm ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, May 15, 2024, followed by the conference call. Conference Call Details Date and Time: Wednesday, May 15, 2024, at 5:00pm ET Call-in Information: Interested parties can access the conference ca